Status:
RECRUITING
Evaluation of the Efficacy of Suprascapular Nerve Block in Adhesive Capsulitis
Lead Sponsor:
CHU de Reims
Conditions:
Adhesive Capsulitis
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This is a double-blind interventional superiority study evaluating the efficacy of suprascapular nerve block in addition to conventional therapies for adhesive capsulitis. Adhesive capsulitis is a pa...
Detailed Description
The glenohumeral joint is a highly mobile joint involving abduction, anterior elevation, external rotation and internal rotation. It is composed of a capsule innervated by the suprascapular nerve. Ret...
Eligibility Criteria
Inclusion
- Patient treated for adhesive capsulitis corresponding to a loss of passive amplitude of more than 20° in external rotation elbow to body and/or abduction in relation to the contralateral shoulder.
- Patient over 18 years of age
- Patient covered by a social security scheme
- Presence of an accompanying person on the day of the procedure for the return trip
- Patient having signed the consent form to participate in the study
Exclusion
- Patient protected by law
- Pregnant women
- Patient who has had shoulder surgery less than six months old
- Patient unable to undergo rehabilitation within one month of surgery
- Allergy to one of the products used (anesthetic, iodinated contrast medium)
- Neuro-orthopedic disorder hampering clinical recovery
- Hemostasis disorder contraindicating block (no discontinuation of anticoagulants according to SFAR recommendations, congenital hemostasis disorder)
Key Trial Info
Start Date :
October 11 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 1 2027
Estimated Enrollment :
62 Patients enrolled
Trial Details
Trial ID
NCT06176248
Start Date
October 11 2024
End Date
March 1 2027
Last Update
December 5 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Chu Reims
Reims, France, 51092